Epoetin Alfa for the Treatment of Anemia Resulting From Chronic Lymphocytic Leukemia

Summary

The purpose of this study is to evaluate the effect of treatment with epoetin alfa versus placebo on the percentage of red blood cells in anemic patients with chronic lymphocytic (white blood cell) leukemia and its effect on the patients' quality-of-life. Epoetin alfa is a genetically engineered protein that stimulates red blood cell production.

Timeline

Start

1990-11

Primary completion

—

Completion

1994-01

Drugs

Indications